Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Researchers in Japan disclose humanized anti-HMGB1 MAbs

Aug. 25, 2014

AVEO Pharmaceuticals presents new anti-GDF-15 MAbs

July 18, 2014

Previously identified RIP1 kinase inhibitor potentially useful for necroptosis

Jan. 24, 2014

P2X1 receptor revealed as a target in transfusion-related acute lung injury

Aug. 6, 2013

Novel autotaxin inhibitors reported by Pfizer

May 23, 2013

Model of hyperoxic injury shows adaptive changes against infection and ROS

Jan. 31, 2013

Novel vitamin E derivative suppresses oxidative stress in animal models of traumatic injury

Jan. 25, 2013

New vaccines for birch pollen allergy presented by Teknologian Tutkimuskeskus

Nov. 20, 2012

Pacific Therapeutics reports encouraging phase I results with combination treatment for fibrosis

Nov. 15, 2012

Researchers at Reata Pharmaceuticals prepare new NO production inhibitors

Oct. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.